Barclays’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4632 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | -$7K | – | 4702 |
|
|
2022
Q1 | $7K | Buy |
+4
| New | +$7K | ﹤0.01% | 4530 |
|
|
2021
Q3 | – | Sell |
-2
| Closed | -$22K | – | 3951 |
|
|
2021
Q2 | $22K | Sell |
2
-10
| -83% | -$110K | ﹤0.01% | 3684 |
|
|
2021
Q1 | $108K | Buy |
12
+8
| +200% | +$72K | ﹤0.01% | 3345 |
|
|
2020
Q4 | $31K | Sell |
4
-2
| -33% | -$15.5K | ﹤0.01% | 3311 |
|
|
2020
Q3 | $37K | Hold |
6
| – | – | ﹤0.01% | 3378 |
|
|
2020
Q2 | $41K | Buy |
6
+3
| +100% | +$20.5K | ﹤0.01% | 3451 |
|
|
2020
Q1 | $18K | Sell |
3
-5
| -63% | -$30K | ﹤0.01% | 3397 |
|
|
2019
Q4 | $119K | Buy |
8
+4
| +100% | +$59.5K | ﹤0.01% | 3392 |
|
|
2019
Q3 | $36K | Sell |
4
-1
| -20% | -$9K | ﹤0.01% | 3754 |
|
|
2019
Q2 | $75K | Sell |
5
-14
| -74% | -$210K | ﹤0.01% | 3708 |
|
|
2019
Q1 | $319K | Buy |
+19
| New | +$319K | ﹤0.01% | 2822 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | -$42K | – | 4294 |
|
|
2018
Q2 | $42K | Buy |
+3
| New | +$42K | ﹤0.01% | 3339 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4197 |
|